Clinical trial
A Multicenter Observational Belgian Study Assessing the Impact of Newly Started Treatment on the QOL in Patients Suffering From Myelodysplastic Syndromes.
NCT04053933 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Observational Belgian Study Assessing the Impact of Newly Started Treatment on the QOL in Patients Suffering From Myelodysplastic Syndromes.
- Lead sponsor
- University Hospital, Antwerp
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2019
- Completion date
- July 31, 2021
- Enrollment
- 70 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.